Results 81 to 90 of about 23,468 (228)

Antibiotic‐mediated immune modulation in periodontitis

open access: yesPeriodontology 2000, EarlyView.
Abstract Periodontitis is a chronic inflammatory disease affecting the supporting structures of the teeth. Although initiated by dysbiotic microbial communities, its progression is largely driven by the host's uncontrolled inflammatory response. While antibiotics have conventionally been employed in periodontitis therapy for their antimicrobial ...
Lina J. Suárez   +6 more
wiley   +1 more source

Protocolo de actuación ante la rosácea en la farmacia comunitaria [PDF]

open access: yes, 2016
La rosácea es una dermatosis facial inflamatoria, recidivante y crónica, que con frecuencia demanda consulta en la farmacia comunitaria. Orientado hacia la práctica clínica del farmacéutico comunitario, este artículo revisa y sintetiza los conceptos ...
Espinosa Suances, Antucho   +1 more
core   +2 more sources

Advances in Bioprinting to Model Immune‐Mediated Skin Diseases

open access: yesAdvanced Healthcare Materials, Volume 15, Issue 9, 6 March 2026.
This review explores how 3D bioprinting drives innovation in developing in vitro skin models that mimic immune‐mediated diseases. It highlights current technologies, key applications in studying skin pathologies, and emerging challenges. The review points toward future opportunities for improving disease modeling and advancing therapeutic and cosmetic ...
Andrea Ulloa‐Fernández   +4 more
wiley   +1 more source

Multi-Transcriptomic Analysis and Experimental Validation Implicate a Central Role of STAT3 in Skin Barrier Dysfunction Induced Aggravation of Rosacea

open access: yesJournal of Inflammation Research, 2022
Yaling Wang,1,2 Ben Wang,1,2 Yingxue Huang,1 Yangfan Li,1,2 Sha Yan,1 Hongfu Xie,1– 3 Yiya Zhang,1– 3 Ji Li1– 3 1Department of Dermatology, Xiangya Hospital, Central South University, Changsha, People’s Republic of China; 2Hunan Key Laboratory of Aging ...
Wang Y   +7 more
doaj  

Sebaceous gland rich skin is characterized by TSLP expression and distinct immune surveillance which is disturbed in rosacea [PDF]

open access: yes, 2017
K
Bácsi, Attila   +12 more
core   +1 more source

Peripheral Neuropathy Induced by a Short Course of Metronidazole: A Case Report of Diagnostic Challenge

open access: yesClinical Case Reports, Volume 14, Issue 3, March 2026.
ABSTRACT Metronidazole is a commonly used antibiotic with a good safety and economic profile, but it may rarely be neurotoxic, causing peripheral neuropathy and encephalopathy. Most literature suggests that prolonged drug therapy, that is, a duration of > 4 weeks and a dosage of > 42 g, is associated with neurotoxicity, though the exact dose‐dependent ...
Sonam Dhenga   +5 more
wiley   +1 more source

Environmental DNA Reveals Diverse and Depth‐Stratified Biodiversity in East Indian Ocean Submarine Canyons

open access: yesEnvironmental DNA, Volume 8, Issue 2, March/April 2026.
Environmental DNA metabarcoding reveals diverse animal communities across Cape Range and Cloates submarine canyons off Western Australia. Two assays detected 234 species spanning 125 families across 11 phyla, highlighting canyon‐specific assemblages and demonstrating the value of eDNA for establishing biodiversity baselines in remote and poorly ...
Georgia M. Nester   +7 more
wiley   +1 more source

El estdo de tres sifonóforos (Cnidaria, Hydrozoa) raros descritos por Tamiji Kawamura: Bathyphysa japonica, Athorybia longifolia and Forskalia misakiensis [PDF]

open access: yes, 2002
[EN] The holotypes of three species inquirendae siphonophores collected in Japanese waters and described by Tamiji Kawamura were re-examined. It is considered that Bathyphysa japonica is not a valid species because there are no characters that ...
Azzam, Rafig   +3 more
core   +3 more sources

Characteristics of Adult Patients With Atopic Dermatitis Initiating Biologics and Janus Kinase Inhibitors in the CorEvitas Atopic Dermatitis Registry

open access: yesJEADV Clinical Practice, Volume 5, Issue 1, Page 101-116, March 2026.
ABSTRACT Background Biologics and Janus kinase inhibitors (JAKi) are two advanced systemic treatment options for patients with atopic dermatitis (AD). The decision to initiate one of these therapies is complex and may be driven by many factors.
Eric L. Simpson   +12 more
wiley   +1 more source

Home - About - Disclaimer - Privacy